Jane Street Group, LLC Cassava Sciences Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 310,600 shares of SAVA stock, worth $726,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
310,600
Previous 120,148 158.51%
Holding current value
$726,804
Previous $1.48 Million 516.32%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$9.57 - $35.08 $413,567 - $1.52 Million
-43,215 Reduced 35.97%
76,933 $2.26 Million
Q2 2024

Aug 14, 2024
BUY
$12.35 - $26.11 $293,448 - $620,399
23,761 Added 24.65%
120,148 $1.48 Million
Q1 2024

May 15, 2024
SELL
$18.44 - $26.41 $5.12 Million - $7.34 Million
-277,819 Reduced 74.24%
96,387 $1.96 Million
Q4 2023

Feb 14, 2024
BUY
$12.64 - $30.11 $4.56 Million - $10.9 Million
360,686 Added 2667.8%
374,206 $8.42 Million
Q3 2023

Nov 14, 2023
SELL
$16.64 - $25.32 $507,020 - $771,500
-30,470 Reduced 69.27%
13,520 $224,000
Q2 2023

Aug 14, 2023
BUY
$21.59 - $27.88 $484,350 - $625,459
22,434 Added 104.07%
43,990 $1.08 Million
Q1 2023

May 15, 2023
BUY
$23.46 - $36.44 $298,458 - $463,589
12,722 Added 144.01%
21,556 $519,000
Q4 2022

Feb 14, 2023
SELL
$27.82 - $44.16 $392,289 - $622,700
-14,101 Reduced 61.48%
8,834 $260,000
Q3 2022

Nov 14, 2022
BUY
$16.33 - $51.06 $126,263 - $394,795
7,732 Added 50.86%
22,935 $959,000
Q2 2022

Aug 16, 2022
BUY
$17.22 - $38.47 $33,957 - $75,862
1,972 Added 14.9%
15,203 $428,000
Q1 2022

May 17, 2022
SELL
$32.6 - $53.05 $3.12 Million - $5.08 Million
-95,812 Reduced 87.87%
13,231 $491,000
Q4 2021

Feb 15, 2022
SELL
$36.77 - $90.91 $1.46 Million - $3.6 Million
-39,607 Reduced 26.64%
109,043 $4.76 Million
Q3 2021

Nov 16, 2021
SELL
$41.79 - $135.3 $1.09 Million - $3.54 Million
-26,181 Reduced 14.98%
148,650 $9.23 Million
Q2 2021

Aug 16, 2021
BUY
$32.15 - $89.72 $3.28 Million - $9.16 Million
102,071 Added 140.28%
174,831 $14.9 Million
Q1 2021

May 18, 2021
BUY
$7.09 - $87.95 $116,857 - $1.45 Million
16,482 Added 29.29%
72,760 $3.27 Million
Q4 2020

Feb 17, 2021
BUY
$6.79 - $12.25 $288,887 - $521,188
42,546 Added 309.83%
56,278 $384,000
Q3 2020

Nov 17, 2020
SELL
$2.86 - $11.51 $232,294 - $934,865
-81,222 Reduced 85.54%
13,732 $158,000
Q2 2020

Aug 17, 2020
BUY
$2.04 - $9.64 $144,778 - $684,150
70,970 Added 295.91%
94,954 $292,000
Q1 2020

May 15, 2020
BUY
$3.26 - $9.65 $21,890 - $64,799
6,715 Added 38.88%
23,984 $99,000
Q4 2019

Feb 14, 2020
BUY
$1.1 - $6.12 $3,606 - $20,067
3,279 Added 23.44%
17,269 $90,000
Q3 2019

Nov 14, 2019
BUY
$1.04 - $1.45 $14,549 - $20,285
13,990 New
13,990 $17,000

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $93.8M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email